During the past decade, Specjalistyczny Szpital miejski im. Kopernika conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Specjalistyczny Szpital miejski im. Kopernika" are "B-Cell Chronic Lymphocytic Leukemia" (1 trials) and "B-cell Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Specjalistyczny Szpital miejski im. Kopernika" in a lesser frequency.

Most popular intervention types in "Specjalistyczny Szpital miejski im. Kopernika" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (2 trials), "Chlorambucil" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Specjalistyczny Szpital miejski im. Kopernika" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Specjalistyczny Szpital miejski im. Kopernika". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Specjalistyczny Szpital miejski im. Kopernika, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Specjalistyczny Szpital miejski im. Kopernika, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".